Abstract
Using a whole-embryo culture system valproic acid (VPA) and some of its metabolites (2-en-VPA, 4-en-VPA, 4,4′-dien-VPA) and analogues (ethyl-propyl-acetic acid, propyl-butyl-acetic acid, di-butyl-acetic acid, 2-methyl-2-ethyl-hexanoic acid, 1-methyl-1-cyclohexanoic acid) were tested for their potential to induce abnormal development. With regard to embryonic growth, development and abnormality rate, the tested compounds showed a wide range of “teratogenic potency” in vitro. In order to verify some of the in vitro results, in vivo experiments were performed. Pregnant rats were treated subcutaneously on day 10 of gestation with 2×330 mg VPA/kg, or 2×400 mg 2-en-VPA/kg, respectively. Evaluation of the embryos was performed on day 11.5 of gestation, corresponding to the in vitro experiments. VPA showed a high potential to induce abnormal development in vivo as well as in vitro, whereas 2-en-VPA was inactive under our experimental conditions. Problems connected with the evaluation of the predictive value of an in vitro test system for the detection of embryotoxic effects, such as “validation” and significance of pharmacokinetic data, are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- VPA:
-
Valproic acid
- EPAA:
-
Ethyl-propyl-acetic acid
- PBAA:
-
Propyl-butyl-acetic acid
- BBAA:
-
Di-butyl-acetic acid
- MEHA:
-
2-methyl-2-ethyl-hexanoic acid
- MCA:
-
Methyl-cyclohexanoic acid
References
Binkerd PE, Rowland JM, Nau H, Hendrickx AG (1988) Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats. Fundam Appl Toxicol 11: 485–493
Brown NA (1987) Teratogenicity of carboxylic acids: distribution studies in whole-embryo culture. In: Nau H, Scott WJ (eds) Pharmacokinetics in teratogenesis, Vol II. CRC Press, Baton Rouge FLA, pp 153–163
Brown NA, Fabro S (1981) Quantitation of rat embryonic development in vitro: A morphological scoring system. Teratology 24: 65–78
Brown NA, Goulding EH, Fabro S (1979) Ethanol embryotoxicity: direct effects on mammalian embryos in vitro. Science 206: 573–575
Brown NA, Coakley ME, Clarke DO (1987) Structure-teratogenicity relationships of valproic acid congeners in whole-embryo culture. In: Welsch F (ed) Approaches to elucidate mechanisms in teratogenesis. Hemisphere Publ Corp, Washington, pp 17–31
Bruckner A, Lee YJ, O'Shea KS, Henneberry RC (1983) Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in culture. Teratology 27: 29–42
Cockroft DL (1977) Post-implantation embryo culture. In: Neubert D, Merker H-J, Kwasigroch TE (eds) Methods in prenatal toxicology. Georg Thieme Publ, Stuttgart-New York, pp 231–240
Cockroft DL (1979), Nutrient requirements of rat embryos undergoing organogenesis in vitro. J Reprod Fert 57: 505–510
Deuchar EM (1971) The mechanism of axial rotation in the rat embryo: an experimental study in vitro. J Embryol Exp Morphol 25: 189–201
Furuhama K, Onodera T (1983) A simple technique for repeated blood collection from the tail vein of the rat. Toxicol Sci 8: 161–163
Gunberg DL (1976) In vitro development of post-implantation rat embryos cultured on dialyzed rat serum. Teratology 14: 65–70
Kao J, Brown NA, Schmid B, Goulding EH, Fabro S (1981) Teratogenicity of valproic acid: in vivo and in vitro investigations. Teratogen Carcinogen Mutagen 1: 367–382
Kimmel GL, Smith K, Kochhar DM, Pratt RM (1982) Overview of in vitro teratogenicity testing: aspects of validation and application to screening. Teratogen Carcinogen Mutagen 2: 221–229
Klug S (1987) Pharmacokinetic studies of valproic acid (VPA) and some of its analogues in the whole-embryo culture system. Naunyn-Schmiedebergs Arch Pharmacol (Suppl) 335: A 112
Klug S, Lewandowski C, Blankenburg G, Merker H-J, Neubert D (1985a) Effects of acyclovir on mammalian embryonic development in culture. Arch Toxicol 58: 89–96
Klug S, Lewandowski C, Neubert D (1985b) Modification and standardization of the culture of early post-implantation embryos for toxicological studies. Arch Toxicol 58: 84–88
Lewandowski C (1987) Whole-embryo culture: Model for simulating various nutritional conditions. Naunyn-Schmiedebergs Arch Pharmacol (Suppl) 335: A 117
Lewandowski C, Klug S, Nau H, Neubert D (1986) Pharmacokinetic aspects of drug effects in vitro: effects of serum protein binding on concentration and teratogenicity of valproic acid and 2-en-valproic acid in whole embryos in culture. Arch Toxicol 58: 239–242
McGarrity C, Samani N, Beck F, Gulamhusein AP (1981) The effect of sodium salicylate on the rat embryo in culture: an in vitro model for the morphological assessment of teratogenicity. J Anat 133: 257–269
Nau H (1986a) Species differences in pharmacokinetics and drug teratogenesis. Environ Health Perspec 70: 113–129
Nau H (1986b) Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: correlation with neural tube defect formation in the mouse. Teratology 33: 21–27
Nau H, Löscher W (1986) Pharmacologic evaluation of various metabolites and analogues of valproic acid — teratogenic potencies in mice. Fundam Appl Toxicol 6: 669–676
Nau H, Wittfoht W, Schäfer H, Jacobs C, Rating D, Helge H (1981) Valproic acid and several metabolites: quantitative determination in serum, urine, breast milk and tissues by gas chromatography-mass spectrometry using selected ion monitoring. J Chromatogr 222: 69–78
Nau H, Lewandowski C, Klug S, Neubert D (1987) Teratogenicity and embryo concentrations of valproic acid and analogues in vitro: comparison to in vivo. Teratology 35: 229 A
Nau H, Lewandowski C, Klug S, Neubert D (1988) Pharmacokinetic aspects of drug effects in vitro (II) Placental transfer to the embryo and activity of some carboxylic acids structurally related to valproic acid in whole-embryos in culture. Toxicol In Vitro 2: 169–174
Neubert D (1985) Toxicity studies with cellular models of differentiation. Xenobiotica 15: 649–660
Neubert D (1986) Zur Vorhersehbarkeit von toxischen Risiken für den Menschen anhand von Ergebnissen aus in-vivo- und in-vitro-Versuchen. In: Burger OK, Grosdanoff P, Henschler D, Kraupp O, Schnieders B (eds) Aktuelle Probleme der Biomedizin. Walter de Gruyter, Berlin-New York, pp 475–483
Neubert D (1989) In vitro techniques for assessing teratogentic potentials. In: Dayan AD, Paine AJ (eds) Advances in applied toxicology. Taylor & Francis Ltd, pp 191–211
Neubert D, Blankenburg G, Lewandowski C, Klug S (1985) Misinterpretations of results and creation of “artifacts” in studies on developmental toxicity using systems simpler than in vivo systems. In: Lash JW, Saxén L (eds) Developmental mechanisms, normal and abnormal progress in clinical and biological research. Alan R Liss Inc, New York, pp 241–266
New DAT (1978) Whole-embryo, culture and the study of mammalian embryos during organogenesis. Biol Rev 53: 81–122
Rawlings SJ, Shuker DEG, Webb M, Brown NA (1985) The teratogenic potential of alkoxy acids in post-implantation rat embryo culture: Structure activity relationships. Toxicol Lett 28: 49–58
Stahlmann R, Klug S, Lewandowski C, Bochert G, Chahoud I, Rahm U, Merker H-J, Neubert D (1988) Prenatal toxicity of acyclovir in rats. Arch Toxicol 61: 468–479
Vorheers C (1987) Teratogenicity and developmental toxicity of valproic acid in rats. Teratology 35: 195–202
Author information
Authors and Affiliations
Additional information
Some of the data presented in this paper are part of the doctoral thesis of Frank Zappel to be presented to the Fachbereich Veterinärmedizin, Freie Universität Berlin.
Rights and permissions
About this article
Cite this article
Klug, S., Lewandowski, C., Zappel, F. et al. Effects of valproic acid, some of its metabolites and analogues on prenatal development of rats in vitro and comparison with effects in vivo. Arch Toxicol 64, 545–553 (1990). https://doi.org/10.1007/BF01971833
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01971833